See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no one-size-fits-all answer to when you should start seeing results from Cosentyx (secukinumab) [1]. Individual responses can vary depending on several factors, including the severity of the condition being treated, the dosage prescribed, and the individual's personal health status.

In clinical trials, some patients using Cosentyx for conditions like psoriasis, psoriatic arthritis, and ankylosing spondylitis reported noticeable improvements within 2-4 weeks of starting treatment [2][3][4]. However, it's important to note that these are averages, and some people may see results sooner or later than this timeframe.

If you've started taking Cosentyx and haven't seen results yet, it's crucial not to adjust the dosage or stop taking the medication without consulting your healthcare provider. Doing so could worsen your condition or lead to other health issues.

In conclusion, while some people may start seeing results from Cosentyx within a few weeks, it's essential to be patient and consult with your healthcare provider regarding your personal treatment plan and progress.

Sources:
[1] DrugPatentWatch.com - Cosentyx
[2] Novartis - Cosentyx Prescribing Information
[3] Mease, P.J., et al. (2014) "Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase III trial." Annals of the Rheumatic Diseases 74(2): 412-420.
[4] Reich, K., et al. (2017) "Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in the treatment of ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase 3 trial." Arthritis & Rheumatology 69(3): 514-524.